Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Atlantic Skin & Cosmetic Surgery Group, PC, Wilmington

Atlanta Dermatology, Vein & Research Center, Alpharetta

Renstar Medical Research, Ocala

Rivergate Dermatology Clinical Research, Goodlettsville

Wright State University, Dayton

Dawes/Fretzin Dermatology Group Inc, Indianapolis

Aurora Advanced Healthcare, Inc, Milwaukee

Minnesota Clinical Study Center, Fridley

NorthShore University HealthSystem, Skokie

Central Dermatology, St Louis

Dermatology & Advanced Aesthetics, Lake Charles

Modern Research Associates, Dallas

Dermatology Associates, Los Angeles

Associates In Research Inc, Fresno

Stanford University School of Medicine, Redwood City

Allergy, Asthma and Dermatology Research Center, Lake Oswego

Northwest Cutaneous Research Specialists, Portland

Oregon Med. Research Center, PC, Portland

Dermatology Associates of Seattle, Seattle

UMDNJ Robert Wood Johnson, New Brunswick

Stratica Medical, Edmonton

Dr. Lorne E. Albrecht, Surrey

Alpha Clinical Research Centre, St. John's

Eastern Canada Cutaneous Research Associates, Halifax

Ultranova Skincare, Barrie

Dermatrials Research Division, Hamilton

Guenther Dermatology Research Centre, London

North Bay Dermatology Centre, North Bay

Dr. Michael Robern, Ottawa

K. Papp Clinical Research Inc., Waterloo

XLR8 Research, Windsor

Innovaderm Research Laval Inc., Laval

Centre De Recherche Dermatologique du Qu, MetSte-Foy

Innovaderm Research Inc., Montreal

International Dermatology Research, Inc., Montreal